Key stats
About CAPITAL INV TRUST CORP NASDAQ BIOTECHNOLOGY ETF TWD
Expense ratio
1.01%
Home page
Inception date
Jan 9, 2017
ISIN
TW0000067800
This fund invests in one basket of United States biotechnology stocks, providing investors with direct participation in the US biotechnology market, which can save investors cost and time. The ETF tracks Nasdaq Biotechnology Index performance as the management target
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Cash
Stocks61.92%
Health Technology61.92%
Bonds, Cash & Other38.08%
Cash36.46%
ETF1.62%
Stock breakdown by region
North America100.00%
Latin America0.00%
Europe0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history